世界の尿路上皮がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Urothelial Carcinoma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5839 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、尿路上皮がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫療法、放射線療法、化学療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・尿路上皮がん治療の市場動向 ・企業の競争状況、市場シェア ・尿路上皮がん治療の種類別市場規模（免疫療法、放射線療法、化学療法） ・尿路上皮がん治療の用途別市場規模（病院、診療所、その他） ・尿路上皮がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・尿路上皮がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・尿路上皮がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・尿路上皮がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・尿路上皮がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Novartis、Merck、Sanofi、Bristol-Myers Squibb、Genentech、Eisai、Dendreon） ・結論

Urothelial carcinoma is also called as transitional cell carcinoma which is a cancerous tumor of the bladder that can spread to other parts of the body. These are also called as malignant tumors. This tumor can start at any part of the urinary tract. People with bladder cancer may also have similar cancer in other parts of the urinary tract.
Americas is likely to dominate the urothelial carcinoma treatment market owing to the increasing prevalence of bladder cancer, increasing investment in research and development of new bladder cancer treatment.

Market Analysis and Insights: Global Urothelial Carcinoma Treatment Market
The global Urothelial Carcinoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Urothelial Carcinoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Urothelial Carcinoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Urothelial Carcinoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Urothelial Carcinoma Treatment market.

Global Urothelial Carcinoma Treatment Scope and Market Size
Urothelial Carcinoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Urothelial Carcinoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunotherapy
Radiotherapy
Chemotherapy

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Novartis
Merck
Sanofi
Bristol-Myers Squibb
Genentech
Eisai
Dendreon

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urothelial Carcinoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunotherapy
1.2.3 Radiotherapy
1.2.4 Chemotherapy
1.3 Market by Application
1.3.1 Global Urothelial Carcinoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Urothelial Carcinoma Treatment Market Perspective (2016-2027)
2.2 Urothelial Carcinoma Treatment Growth Trends by Regions
2.2.1 Urothelial Carcinoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Urothelial Carcinoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Urothelial Carcinoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Urothelial Carcinoma Treatment Industry Dynamic
2.3.1 Urothelial Carcinoma Treatment Market Trends
2.3.2 Urothelial Carcinoma Treatment Market Drivers
2.3.3 Urothelial Carcinoma Treatment Market Challenges
2.3.4 Urothelial Carcinoma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Urothelial Carcinoma Treatment Players by Revenue
3.1.1 Global Top Urothelial Carcinoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Urothelial Carcinoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Urothelial Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Urothelial Carcinoma Treatment Revenue
3.4 Global Urothelial Carcinoma Treatment Market Concentration Ratio
3.4.1 Global Urothelial Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urothelial Carcinoma Treatment Revenue in 2020
3.5 Urothelial Carcinoma Treatment Key Players Head office and Area Served
3.6 Key Players Urothelial Carcinoma Treatment Product Solution and Service
3.7 Date of Enter into Urothelial Carcinoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Urothelial Carcinoma Treatment Breakdown Data by Type
4.1 Global Urothelial Carcinoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Urothelial Carcinoma Treatment Forecasted Market Size by Type (2022-2027)

5 Urothelial Carcinoma Treatment Breakdown Data by Application
5.1 Global Urothelial Carcinoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Urothelial Carcinoma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Urothelial Carcinoma Treatment Market Size (2016-2027)
6.2 North America Urothelial Carcinoma Treatment Market Size by Type
6.2.1 North America Urothelial Carcinoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Urothelial Carcinoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Urothelial Carcinoma Treatment Market Size by Type (2016-2027)
6.3 North America Urothelial Carcinoma Treatment Market Size by Application
6.3.1 North America Urothelial Carcinoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Urothelial Carcinoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Urothelial Carcinoma Treatment Market Size by Application (2016-2027)
6.4 North America Urothelial Carcinoma Treatment Market Size by Country
6.4.1 North America Urothelial Carcinoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Urothelial Carcinoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Urothelial Carcinoma Treatment Market Size (2016-2027)
7.2 Europe Urothelial Carcinoma Treatment Market Size by Type
7.2.1 Europe Urothelial Carcinoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Urothelial Carcinoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Urothelial Carcinoma Treatment Market Size by Type (2016-2027)
7.3 Europe Urothelial Carcinoma Treatment Market Size by Application
7.3.1 Europe Urothelial Carcinoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Urothelial Carcinoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Urothelial Carcinoma Treatment Market Size by Application (2016-2027)
7.4 Europe Urothelial Carcinoma Treatment Market Size by Country
7.4.1 Europe Urothelial Carcinoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Urothelial Carcinoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Urothelial Carcinoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Urothelial Carcinoma Treatment Market Size by Type
8.2.1 Asia-Pacific Urothelial Carcinoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Urothelial Carcinoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Urothelial Carcinoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Urothelial Carcinoma Treatment Market Size by Application
8.3.1 Asia-Pacific Urothelial Carcinoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Urothelial Carcinoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Urothelial Carcinoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Urothelial Carcinoma Treatment Market Size by Region
8.4.1 Asia-Pacific Urothelial Carcinoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Urothelial Carcinoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Urothelial Carcinoma Treatment Market Size (2016-2027)
9.2 Latin America Urothelial Carcinoma Treatment Market Size by Type
9.2.1 Latin America Urothelial Carcinoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Urothelial Carcinoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Urothelial Carcinoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Urothelial Carcinoma Treatment Market Size by Application
9.3.1 Latin America Urothelial Carcinoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Urothelial Carcinoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Urothelial Carcinoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Urothelial Carcinoma Treatment Market Size by Country
9.4.1 Latin America Urothelial Carcinoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Urothelial Carcinoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Urothelial Carcinoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Urothelial Carcinoma Treatment Market Size by Type
10.2.1 Middle East & Africa Urothelial Carcinoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Urothelial Carcinoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Urothelial Carcinoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Urothelial Carcinoma Treatment Market Size by Application
10.3.1 Middle East & Africa Urothelial Carcinoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Urothelial Carcinoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Urothelial Carcinoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Urothelial Carcinoma Treatment Market Size by Country
10.4.1 Middle East & Africa Urothelial Carcinoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Urothelial Carcinoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Urothelial Carcinoma Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Urothelial Carcinoma Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Urothelial Carcinoma Treatment Introduction
11.2.4 Novartis Revenue in Urothelial Carcinoma Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Urothelial Carcinoma Treatment Introduction
11.3.4 Merck Revenue in Urothelial Carcinoma Treatment Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Urothelial Carcinoma Treatment Introduction
11.4.4 Sanofi Revenue in Urothelial Carcinoma Treatment Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Urothelial Carcinoma Treatment Introduction
11.5.4 Bristol-Myers Squibb Revenue in Urothelial Carcinoma Treatment Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Genentech
11.6.1 Genentech Company Details
11.6.2 Genentech Business Overview
11.6.3 Genentech Urothelial Carcinoma Treatment Introduction
11.6.4 Genentech Revenue in Urothelial Carcinoma Treatment Business (2016-2021)
11.6.5 Genentech Recent Development
11.7 Eisai
11.7.1 Eisai Company Details
11.7.2 Eisai Business Overview
11.7.3 Eisai Urothelial Carcinoma Treatment Introduction
11.7.4 Eisai Revenue in Urothelial Carcinoma Treatment Business (2016-2021)
11.7.5 Eisai Recent Development
11.8 Dendreon
11.8.1 Dendreon Company Details
11.8.2 Dendreon Business Overview
11.8.3 Dendreon Urothelial Carcinoma Treatment Introduction
11.8.4 Dendreon Revenue in Urothelial Carcinoma Treatment Business (2016-2021)
11.8.5 Dendreon Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Urothelial Carcinoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Chemotherapy
Table 5. Global Urothelial Carcinoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Urothelial Carcinoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Urothelial Carcinoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Urothelial Carcinoma Treatment Market Share by Regions (2016-2021)
Table 9. Global Urothelial Carcinoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Urothelial Carcinoma Treatment Market Share by Regions (2022-2027)
Table 11. Urothelial Carcinoma Treatment Market Trends
Table 12. Urothelial Carcinoma Treatment Market Drivers
Table 13. Urothelial Carcinoma Treatment Market Challenges
Table 14. Urothelial Carcinoma Treatment Market Restraints
Table 15. Global Urothelial Carcinoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Urothelial Carcinoma Treatment Market Share by Players (2016-2021)
Table 17. Global Top Urothelial Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urothelial Carcinoma Treatment as of 2020)
Table 18. Ranking of Global Top Urothelial Carcinoma Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Urothelial Carcinoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Urothelial Carcinoma Treatment Product Solution and Service
Table 22. Date of Enter into Urothelial Carcinoma Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Urothelial Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Urothelial Carcinoma Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Urothelial Carcinoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Urothelial Carcinoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Urothelial Carcinoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Urothelial Carcinoma Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Urothelial Carcinoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Urothelial Carcinoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Urothelial Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Urothelial Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Urothelial Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Urothelial Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Urothelial Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Urothelial Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Urothelial Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Urothelial Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Urothelial Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Urothelial Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Urothelial Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Urothelial Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Urothelial Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Urothelial Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Urothelial Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Urothelial Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Urothelial Carcinoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Urothelial Carcinoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Urothelial Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Urothelial Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Urothelial Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Urothelial Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Urothelial Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Urothelial Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Urothelial Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Urothelial Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Urothelial Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Urothelial Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Urothelial Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Urothelial Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. GlaxoSmithKline Company Details
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Urothelial Carcinoma Treatment Product
Table 65. GlaxoSmithKline Revenue in Urothelial Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Urothelial Carcinoma Treatment Product
Table 70. Novartis Revenue in Urothelial Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Merck Company Details
Table 73. Merck Business Overview
Table 74. Merck Urothelial Carcinoma Treatment Product
Table 75. Merck Revenue in Urothelial Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 76. Merck Recent Development
Table 77. Sanofi Company Details
Table 78. Sanofi Business Overview
Table 79. Sanofi Urothelial Carcinoma Treatment Product
Table 80. Sanofi Revenue in Urothelial Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 81. Sanofi Recent Development
Table 82. Bristol-Myers Squibb Company Details
Table 83. Bristol-Myers Squibb Business Overview
Table 84. Bristol-Myers Squibb Urothelial Carcinoma Treatment Product
Table 85. Bristol-Myers Squibb Revenue in Urothelial Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 86. Bristol-Myers Squibb Recent Development
Table 87. Genentech Company Details
Table 88. Genentech Business Overview
Table 89. Genentech Urothelial Carcinoma Treatment Product
Table 90. Genentech Revenue in Urothelial Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 91. Genentech Recent Development
Table 92. Eisai Company Details
Table 93. Eisai Business Overview
Table 94. Eisai Urothelial Carcinoma Treatment Product
Table 95. Eisai Revenue in Urothelial Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 96. Eisai Recent Development
Table 97. Dendreon Company Details
Table 98. Dendreon Business Overview
Table 99. Dendreon Revenue in Urothelial Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 100. Dendreon Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Urothelial Carcinoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Immunotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Chemotherapy Features
Figure 5. Global Urothelial Carcinoma Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Urothelial Carcinoma Treatment Report Years Considered
Figure 10. Global Urothelial Carcinoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Urothelial Carcinoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Urothelial Carcinoma Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Urothelial Carcinoma Treatment Market Share by Regions (2022-2027)
Figure 14. Global Urothelial Carcinoma Treatment Market Share by Players in 2020
Figure 15. Global Top Urothelial Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urothelial Carcinoma Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Urothelial Carcinoma Treatment Revenue in 2020
Figure 17. Global Urothelial Carcinoma Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Urothelial Carcinoma Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Urothelial Carcinoma Treatment Market Share by Type (2016-2027)
Figure 21. North America Urothelial Carcinoma Treatment Market Share by Application (2016-2027)
Figure 22. North America Urothelial Carcinoma Treatment Market Share by Country (2016-2027)
Figure 23. United States Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Urothelial Carcinoma Treatment Market Share by Type (2016-2027)
Figure 27. Europe Urothelial Carcinoma Treatment Market Share by Application (2016-2027)
Figure 28. Europe Urothelial Carcinoma Treatment Market Share by Country (2016-2027)
Figure 29. Germany Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Urothelial Carcinoma Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Urothelial Carcinoma Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Urothelial Carcinoma Treatment Market Share by Region (2016-2027)
Figure 39. China Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Urothelial Carcinoma Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Urothelial Carcinoma Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Urothelial Carcinoma Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Urothelial Carcinoma Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Urothelial Carcinoma Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Urothelial Carcinoma Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Urothelial Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2016-2021)
Figure 63. Genentech Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2016-2021)
Figure 64. Eisai Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2016-2021)
Figure 65. Dendreon Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---